Value of Liquid-Based Cytology Test Combined with HR-HPV Testing in CIN III after LLETZ During Follow-Up

Zhang Yan-ping,Ruifang Wu,Fei Liu,Tang Huiru,Chun Wang,Zhou Yanqiu
2013-01-01
Abstract:Objective:This study aimed to evaluate the value of liquid-based cytology test(LCT)combined with high-risk human papillomavirus(HR-HPV)testing in cervical intraepithelial neoplasia gradeIII(CINIII)after large-loop excision of the transformation zone(LLETZ)during follow-up. Methods:Clinical analysis was used to investigate 567 patients diagnosed with CINIII and treated with LLETZ from May 2003 to May 2009 at Peking University Shenzhen Hospital. The patients were enrolled in a follow-up program set at 3 months, 6 months, and every 6 to 12 months. LCT and HR-HPV testing were used as monitoring indicators to evaluate HR-HPV testing after LLETZ during follow-up. Results:1)The residual lesion predicting capacity of postoperative LCT obtained the following: sensitivity, 60%: specificity, 88.15%: positive predictive value, 8.30%; and negative predictive value, 99.19%. The residual lesion predicting capacity of HPV testing obtained the following: sensitivity, 100%: specificity, 85.64%: positive predictive value, 11.11%; and negative predictive value, 100%. The recurrent lesion predicting capacity of postoperative LCT obtained the following: sensitivity, 63.64%; specificity, 92.27%; positive predictive value, 14.00%; and negative predictive value, 99.23%. The recurrent lesion predicting capacity of HPV testing obtained the following: sensitivity, 72.73%; specificity 85.97%; positive predictive value 9.30%; and negative predictive value, 99.38%. 2)The recurrent lesion rate was higher in postoperative persistent HPV infection patients than in non-postoperative persistent HPV infection patients , Ther were statistically significant differences between the persistent negative and non-testing preoperative group(P<0.05). The recurrence rate was higher in persistent HPV-positive and HPV-re-infected patients than in the negative conversion group, whereas no recurrent lesion was found in persistent HPV-negative patients. Conclusion:Results showed the importance of predicting residual and recurrent lesions by LCT and HR-HPV testing, which were also confirmed to be effective methods in follow up. Postoperative persistent HPV-positive status is associated with recurrence and requires consistent follow-up.
What problem does this paper attempt to address?